# RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

> **NCT06813820** · NA · RECRUITING · sponsor: **BioVentrix** · enrollment: 135 (estimated)

## Conditions studied

- Left Ventricle Remodeling
- Left Ventricle Dilated
- CHF

## Interventions

- **DEVICE:** Revivent System

## Key facts

- **NCT ID:** NCT06813820
- **Lead sponsor:** BioVentrix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-29
- **Primary completion:** 2028-08
- **Final completion:** 2032-08
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813820, "RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06813820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*